Report
Seth Goldstein
EUR 850.00 For Business Accounts Only

Morningstar | With Our Long-Term Lithium Outlook Intact, We Maintain Our Livent FVE; Shares Undervalued. See Updated Analyst Note from 13 Feb 2019

Livent reported decent fourth-quarter results as adjusted EBITDA grew 5% year on year. Higher volume and favorable foreign-exchange movements were partially offset by higher operating costs. In its 2019 outlook, Livent noted it is facing declining prices and weaker demand from its longer-term contract customers in China for lithium hydroxide. This is in line with our outlook that lithium prices will fall over the medium term from current prices around $12,000 per metric ton (on a Chilean export LCE basis) to $10,000 as new supply outpaces demand growth. However, as electric vehicle adoption continues to grow, we forecast higher long-term lithium prices as higher-cost supply will be needed to meet demand. With our outlook largely intact, we maintain our $18 fair value estimate for narrow-moat Livent.

In its 2019 guidance, Livent disclosed that it will purchase third-party lithium carbonate to supply a portion of its feedstock to produce lithium hydroxide. We continue to think that Livent's lithium hydroxide strategy comes with additional risk. We attribute Livent's excess returns to its low-cost lithium carbonate and lithium chloride production. By purchasing third-party carbonate, Livent's margins will fall regardless of lithium price movements, as margins will also be tied to the spread between carbonate and hydroxide. Given our outlook that demand for both lithium carbonate and hydroxide will continue to be strong, we would prefer that Livent focus on the production of low-cost lithium carbonate over the production of hydroxide, which does not carry the same cost advantage.

FMC announced it will fully spin off Livent on March 1. Although Livent is a publicly traded company, FMC still owns roughly 85% of shares outstanding. Once Livent is spun off, it will be able to fully operate as a separate entity without needing to receive FMC's approval for capital-allocation decisions.

For more information on our lithium outlook, please see our Nov. 30 report, "Put the Pedal to the Metal for Lithium Stocks."

For more information on our electric vehicle forecast, please see our Sept. 24 Observer, "Electric Vehicle Sales in China and Europe Will Leave U.S. in the Dust, Driving Above-Consensus Global Adoption Rates."
Underlying
Livent

Livent manufactures lithium. The company's primary products, namely battery-grade lithium hydroxide, butyllithium and high purity lithium metal are inputs used in various applications. The company produces lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in lithium-ion batteries. The company also supplies butyllithium, which is used as a synthesizer in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds including high purity lithium metal, which is used in the production of lightweight materials for aerospace applications and non-rechargeable batteries.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Seth Goldstein

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch